Amrize stock draws attention as Allspring cuts stake
Published on 11/13/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMixed Signals From Institutional Investors
- Allspring cut its Amrize position by 53.2 percent in the third quarter.
- Other institutions added shares, while company insiders bought stock in recent months.
- Analysts tracked by MarketBeat held a consensus rating of Hold with an average price target of 47.65 US dollars.
Amrize is facing a mixed signal from institutional investors after Allspring Global Investments cut its position sharply in the third quarter. The filing-based figures were reported by MarketBeat on Wednesday, November 11.
Allspring sold 1,629,684 shares during the third quarter and held 1,433,200 shares afterward, according to the report. The remaining position represented about 0.26 percent of Amrize and was valued at 53.387 million US dollars at the end of the period.
Institutional Flows Point In Both Directions
The reduction was not matched across the entire shareholder base. Pictet Asset Management increased its position by 4.3 percent to 6,126,150 shares, while CenterBook Partners expanded its holding by 1,123.6 percent to 101,408 shares. Kestra Asset Management, Rakuten Investment Management and Bank Julius Baer also increased or initiated positions during the quarter.
Insider activity provided another counterpoint. MarketBeat reported purchases totaling 34,155 shares worth 1.461276 million US dollars over the preceding three months. Chief Executive Jan Jenisch bought 26,000 shares on September 2 at an average price of 42.47 US dollars, while director Jacques Sanche acquired 4,150 shares on August 26 at an average of 45.02 US dollars.
Earnings And Analyst Expectations
Amrize reported third-quarter earnings of 1.05 US dollars per share, matching the consensus cited by MarketBeat. Revenue rose 2.6 percent year over year to 3.77 billion US dollars, while the company also recently declared a quarterly dividend of 0.11 US dollars per share payable on Wednesday, November 18.
Analyst opinion remained mixed. MarketBeat cited a consensus Hold rating from 19 analysts and an average price target of 47.65 US dollars. Oppenheimer lowered its target to 52 US dollars while maintaining an Outperform rating, and Berenberg cut its rating from Buy to Hold while reducing its target from 48 to 46 US dollars.
Amrize stock traded at 36.94 euros on Lang & Schwarz at 10:07 CET on Friday, November 13.
Amrize Company Facts
- Company: Amrize Ltd
- ISIN: CH1430134226
- Primary listing: New York Stock Exchange
- Lang & Schwarz quote: 36.94 euros on November 13, 2026, at 10:07 CET
- Third-quarter revenue: 3.77 billion US dollars
- Quarterly dividend: 0.11 US dollars per share, payable November 18, 2026
The wider US market environment remains relevant for building-materials companies; investors can follow current S&P 500 market reports.
For further company-specific developments, see More news and analyses on Amrize stock.
